Compile Data Set for Download or QSAR
Report error Found 52 Enz. Inhib. hit(s) with all data for entry = 50010792
TargetProtein kinase C zeta type(Human)
Asahi Kasei Pharma

Curated by ChEMBL
LigandPNGBDBM50542127(CHEMBL4635482)
Affinity DataIC50: 0.100nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetProtein kinase C zeta type(Human)
Asahi Kasei Pharma

Curated by ChEMBL
LigandPNGBDBM50542123(CHEMBL4636488)
Affinity DataIC50: 0.200nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetProtein kinase C zeta type(Human)
Asahi Kasei Pharma

Curated by ChEMBL
LigandPNGBDBM50542116(CHEMBL4646995)
Affinity DataIC50: 0.5nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetProtein kinase C zeta type(Human)
Asahi Kasei Pharma

Curated by ChEMBL
LigandPNGBDBM50542119(CHEMBL4644939)
Affinity DataIC50: 0.600nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetProtein kinase C zeta type(Human)
Asahi Kasei Pharma

Curated by ChEMBL
LigandPNGBDBM50542128(CHEMBL4636337)
Affinity DataIC50: 0.800nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetProtein kinase C zeta type(Human)
Asahi Kasei Pharma

Curated by ChEMBL
LigandPNGBDBM50542132(CHEMBL4632523)
Affinity DataIC50: 0.900nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetProtein kinase C zeta type(Human)
Asahi Kasei Pharma

Curated by ChEMBL
LigandPNGBDBM50542133(CHEMBL4643553)
Affinity DataIC50: 1.10nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetProtein kinase C zeta type(Human)
Asahi Kasei Pharma

Curated by ChEMBL
LigandPNGBDBM50542126(CHEMBL4642166)
Affinity DataIC50: 1.40nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetProtein kinase C zeta type(Human)
Asahi Kasei Pharma

Curated by ChEMBL
LigandPNGBDBM50542129(CHEMBL4637452)
Affinity DataIC50: 1.40nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetProtein kinase C zeta type(Human)
Asahi Kasei Pharma

Curated by ChEMBL
LigandPNGBDBM50542134(CHEMBL4647780)
Affinity DataIC50: 3.40nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetProtein kinase C zeta type(Human)
Asahi Kasei Pharma

Curated by ChEMBL
LigandPNGBDBM50542125(CHEMBL4643470)
Affinity DataIC50: 4.10nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetProtein kinase C zeta type(Human)
Asahi Kasei Pharma

Curated by ChEMBL
LigandPNGBDBM50542121(CHEMBL4641918)
Affinity DataIC50: 6.40nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetProtein kinase C zeta type(Human)
Asahi Kasei Pharma

Curated by ChEMBL
LigandPNGBDBM50542130(CHEMBL4632384)
Affinity DataIC50: 9.70nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetProtein kinase C zeta type(Human)
Asahi Kasei Pharma

Curated by ChEMBL
LigandPNGBDBM50542111(CHEMBL4644763)
Affinity DataIC50: 13nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetProtein kinase C zeta type(Human)
Asahi Kasei Pharma

Curated by ChEMBL
LigandPNGBDBM50542122(CHEMBL4642061)
Affinity DataIC50: 13nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetProtein kinase C zeta type(Human)
Asahi Kasei Pharma

Curated by ChEMBL
LigandPNGBDBM50542131(CHEMBL4634517)
Affinity DataIC50: 15nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase D2(Human)
Asahi Kasei Pharma

Curated by ChEMBL
LigandPNGBDBM50542119(CHEMBL4644939)
Affinity DataIC50: 17nMAssay Description:Inhibition of PKD2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetProtein kinase C zeta type(Human)
Asahi Kasei Pharma

Curated by ChEMBL
LigandPNGBDBM50542100(CHEMBL4645728)
Affinity DataIC50: 33nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetProtein kinase C zeta type(Human)
Asahi Kasei Pharma

Curated by ChEMBL
LigandPNGBDBM50542124(CHEMBL4641607)
Affinity DataIC50: 35nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetProtein kinase C zeta type(Human)
Asahi Kasei Pharma

Curated by ChEMBL
LigandPNGBDBM50542127(CHEMBL4635482)
Affinity DataIC50: 45nMAssay Description:Inhibition of PKCzeta in human THP1 cells assessed as reduction in LPS-induced TNFalpha production pre-incubated for 60 mins before LPS simulations f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetProtein kinase C zeta type(Human)
Asahi Kasei Pharma

Curated by ChEMBL
LigandPNGBDBM50542120(CHEMBL4648006)
Affinity DataIC50: 54nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase D2(Human)
Asahi Kasei Pharma

Curated by ChEMBL
LigandPNGBDBM50542117(CHEMBL4640042)
Affinity DataIC50: 102nMAssay Description:Inhibition of PKD2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetProtein kinase C zeta type(Human)
Asahi Kasei Pharma

Curated by ChEMBL
LigandPNGBDBM50542114(CHEMBL4646074)
Affinity DataIC50: 109nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetProtein kinase C zeta type(Human)
Asahi Kasei Pharma

Curated by ChEMBL
LigandPNGBDBM50542103(CHEMBL4639268)
Affinity DataIC50: 141nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetProtein kinase C zeta type(Human)
Asahi Kasei Pharma

Curated by ChEMBL
LigandPNGBDBM50542101(CHEMBL4641149)
Affinity DataIC50: 142nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase D2(Human)
Asahi Kasei Pharma

Curated by ChEMBL
LigandPNGBDBM50542123(CHEMBL4636488)
Affinity DataIC50: 144nMAssay Description:Inhibition of PKD2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetProtein kinase C zeta type(Human)
Asahi Kasei Pharma

Curated by ChEMBL
LigandPNGBDBM50542102(CHEMBL4633764)
Affinity DataIC50: 147nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetProtein kinase C zeta type(Human)
Asahi Kasei Pharma

Curated by ChEMBL
LigandPNGBDBM50542118(CHEMBL4645229)
Affinity DataIC50: 153nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetProtein kinase C zeta type(Human)
Asahi Kasei Pharma

Curated by ChEMBL
LigandPNGBDBM50542117(CHEMBL4640042)
Affinity DataIC50: 162nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase D2(Human)
Asahi Kasei Pharma

Curated by ChEMBL
LigandPNGBDBM50542118(CHEMBL4645229)
Affinity DataIC50: 187nMAssay Description:Inhibition of PKD2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase D2(Human)
Asahi Kasei Pharma

Curated by ChEMBL
LigandPNGBDBM50542125(CHEMBL4643470)
Affinity DataIC50: 202nMAssay Description:Inhibition of PKD2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase D2(Human)
Asahi Kasei Pharma

Curated by ChEMBL
LigandPNGBDBM50542116(CHEMBL4646995)
Affinity DataIC50: 246nMAssay Description:Inhibition of PKD2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase D2(Human)
Asahi Kasei Pharma

Curated by ChEMBL
LigandPNGBDBM50542121(CHEMBL4641918)
Affinity DataIC50: 261nMAssay Description:Inhibition of PKD2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase D2(Human)
Asahi Kasei Pharma

Curated by ChEMBL
LigandPNGBDBM50542120(CHEMBL4648006)
Affinity DataIC50: 263nMAssay Description:Inhibition of PKD2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetProtein kinase C zeta type(Human)
Asahi Kasei Pharma

Curated by ChEMBL
LigandPNGBDBM50542112(CHEMBL4638383)
Affinity DataIC50: 321nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetProtein kinase C zeta type(Human)
Asahi Kasei Pharma

Curated by ChEMBL
LigandPNGBDBM50542108(CHEMBL4641174)
Affinity DataIC50: 356nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetProtein kinase C zeta type(Human)
Asahi Kasei Pharma

Curated by ChEMBL
LigandPNGBDBM50542113(CHEMBL4644160)
Affinity DataIC50: 604nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetProtein kinase C zeta type(Human)
Asahi Kasei Pharma

Curated by ChEMBL
LigandPNGBDBM50542110(CHEMBL4644798)
Affinity DataIC50: 631nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase D2(Human)
Asahi Kasei Pharma

Curated by ChEMBL
LigandPNGBDBM50542122(CHEMBL4642061)
Affinity DataIC50: 762nMAssay Description:Inhibition of PKD2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetProtein kinase C zeta type(Human)
Asahi Kasei Pharma

Curated by ChEMBL
LigandPNGBDBM50542109(CHEMBL4649466)
Affinity DataIC50: 1.01E+3nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetProtein kinase C zeta type(Human)
Asahi Kasei Pharma

Curated by ChEMBL
LigandPNGBDBM50542107(CHEMBL4633447)
Affinity DataIC50: 1.07E+3nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase D2(Human)
Asahi Kasei Pharma

Curated by ChEMBL
LigandPNGBDBM50542126(CHEMBL4642166)
Affinity DataIC50: 1.19E+3nMAssay Description:Inhibition of PKD2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetProtein kinase C zeta type(Human)
Asahi Kasei Pharma

Curated by ChEMBL
LigandPNGBDBM50542104(CHEMBL4649829)
Affinity DataIC50: 1.25E+3nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetProtein kinase C zeta type(Human)
Asahi Kasei Pharma

Curated by ChEMBL
LigandPNGBDBM50542115(CHEMBL4634587)
Affinity DataIC50: 1.39E+3nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetProtein kinase C zeta type(Human)
Asahi Kasei Pharma

Curated by ChEMBL
LigandPNGBDBM50542097(CHEMBL4633862)
Affinity DataIC50: 2.00E+3nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase D2(Human)
Asahi Kasei Pharma

Curated by ChEMBL
LigandPNGBDBM50542124(CHEMBL4641607)
Affinity DataIC50: 3.32E+3nMAssay Description:Inhibition of PKD2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetProtein kinase C zeta type(Human)
Asahi Kasei Pharma

Curated by ChEMBL
LigandPNGBDBM50542105(CHEMBL4648633)
Affinity DataIC50: 3.64E+3nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetProtein kinase C zeta type(Human)
Asahi Kasei Pharma

Curated by ChEMBL
LigandPNGBDBM50542111(CHEMBL4644763)
Affinity DataIC50: 8.00E+3nMAssay Description:Inhibition of PKCzeta in human THP1 cells assessed as reduction in LPS-induced TNFalpha production pre-incubated for 60 mins before LPS simulations f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetProtein kinase C zeta type(Human)
Asahi Kasei Pharma

Curated by ChEMBL
LigandPNGBDBM50542098(CHEMBL4645167)
Affinity DataIC50: 1.40E+4nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetProtein kinase C zeta type(Human)
Asahi Kasei Pharma

Curated by ChEMBL
LigandPNGBDBM50542096(CHEMBL4637961)
Affinity DataIC50: 2.60E+4nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
Displayed 1 to 50 (of 52 total ) | Next | Last >>
Jump to: